Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
109
datasets available to search
ShareScore release 0.9.0
Dataset results
109 results for “primary central nervous system lymphoma”
Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)
ClinicalTrials.gov study NCT03581942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT07015242. IPD Sharing: YES. Countries: 3. Publications: 0.
Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT04083066. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT04737889. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT05260619. IPD Sharing: NO. Countries: 1. Publications: 0.
Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL)
ClinicalTrials.gov study NCT05549284. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT03558750. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT00003261. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System
ClinicalTrials.gov study NCT03495960. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)
ClinicalTrials.gov study NCT04947319. IPD Sharing: NO. Countries: 1. Publications: 0.
Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy
ClinicalTrials.gov study NCT03690895. IPD Sharing: NO. Countries: 1. Publications: 0.
Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B Cell Lymphomas
ClinicalTrials.gov study NCT05133505. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Prospective Comparison of 18F-FDG and 18F-FET PET for Response Evaluation in Patients With Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT05083936. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Orelabrutinib Maintenance Therapy After ASCT in Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT05334238. IPD Sharing: NO. Countries: 1. Publications: 0.
A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL)
ClinicalTrials.gov study NCT04129710. IPD Sharing: YES. Countries: 1. Publications: 0.
a Phase II Study in Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT00455286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT04462328. IPD Sharing: NO. Countries: 1. Publications: 0.
Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT00293475. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)
ClinicalTrials.gov study NCT00916630. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
ClinicalTrials.gov study NCT00003929. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.